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Human immunodeficiency virus (HIV1) has been associated with acquired im-
munodeficiency syndrome (AIDS) in man (1-4). Development of successful immu-
nization and/or therapeutic regimens for AIDS has been hampered by the lack of
easily manipulated animal models for HIV-1 infection (5). Recent reports (6, 7) sug-
gest that rabbits may be useful for the study of HIV-1 infection. In the present study
rabbits previously infected with HTLV1, as well as normal rabbits, were injected
with a human T cell line infected with HIV-1. Both groups showed signs of HIV-1
infection, which were substantiated using serologic, biologic, and molecular analyses.
Materials and Methods
Rabbits.
￿
Outbred New Zealand white rabbits were maintained under specific pathogen-
free conditions in biosafety level 2 (BSL-2) facilities and all manipulations were carried out
observing strict BSL-3 practice (8).
Viral Inoculation.
￿
Rabbits were infected with HTLV1 by intravenous injection of 5 x 106
irradiated MT-2 cells (9). For HIV-1 infection, rabbits were given an intravenous injection
of 5 x 106 A3.01 cells (10) at near peak HIV-1 infection as determined by reverse transcrip-
tase (RT) activity (11). Control animals were given 5 x 106 uninfected A3.01 cells.
Serologic Testing
￿
Serum samples were tested at 3-wk intervals post-infection for antibodies
directed against HTLV1 and HIV-1 proteins using ELISA kits from DuPont Co. (Wilmington,
DE). Western blot analyses were carried out using nitrocellulose strips containing HIV-1 pro-
teins(Epitope Inc., Beaverton, OR) and gold-labeled goat anti-rabbit IgG (Janssen, Piscata-
way, NJ).
Culture ofRabbit PBL.
￿
Blood samples were taken at 3-wk intervals post-infection. PBL,
prepared by Ficoll/Hypaque separation (6), were cultured in medium containing humanrIL-2
(20 U/ml; Genzyme, Boston, MA) ; a second aliquot was cocultured with A3.01 cells at a
1 :1 ratio. Cultures were monitored for syncytia formation and supernatants for RT activity.
Cell-free supernatants from PBL or PBL/A3.01 cocultures were incubated with A3.01 cells
in order to amplify the virus; infected cells were pelleted and stored at -70°C.
Gene Amplification by Polymerase Chain Reaction (PCR).
￿
PCR (Perkin-Elmer Corp., Norwalk,
CT) was performed on genomic DNA extracted from cell pellets using oligonucleotide primers
complementary to conserved regions in the HIV-1 gag gene. Aliquots of amplified samples
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were subjected to electrophoresis on 3% NuSieve/1% Sea Kern agarose (FMC BioProducts,
Rockland, ME) and to Southern blot analysis (ONCOR Sure blot) using a 32p-labeled probe
specific for the HIV-1 gag region (12, 13).
Necropsy ofInfectedAnimals.
￿
At various time points post-infection, heavily sedated rabbits
were exsanguinated by cardiac puncture. Spleens were taken under sterile conditions and
divided into portions for cell culture and for pathology. Flow cytometry analysis was carried
out on spleen cells using antibody reagents for human (Becton Dickinson & Co., Mountain
View, CA) and rabbit lymphoid cell populations (14). Organs were fixed in neutral formalin
and sent to a veterinary pathology lab (Maryland Medical Inc., Baltimore, MD) for diagnosis.
Results
Four groups ofexperimental and control rabbits were formed for infections with
HIV1: group 1 consisted of five rabbits infected with HTLV1; group 2 consisted
of three rabbits injected with HIV-1-infected A3.01 cells; group 3 consisted of six
rabbits seropositive for HTLV1 subsequently injected with HIV-1-infected A3 .01
cells; and group 4 consisted of two control rabbits given A3 .01 cellsnot infected with
HIV1.
SerologicAnalyses ofInfected Rabbits.
￿
Within N6 wk all rabbits injected with HIV-1
were seropositive for HIVI. Rabbits seropositive for HTLV1 before injection ofHIV-1
became seropositive sooner and gave stronger responses than those infected with
HIV-1 only. No crossreactivity between HTLV1 and HIV-l' sera was observed by
ELISA, and sera from control rabbits were negative in both assays. Positive samples
were shown by Western Blot analyses to have antibodies directed against various
HIV-1 proteins.
IsolationandCharacterization ofHIV-1fiom Infected Rabbits.
￿
Observation ofPBL cul-
tures revealed formation of syncytia in thosetaken from HIV-1-infected rabbits. Fig.
1 shows PBL from uninfected (A), HIV-1-(B), and HTLV1/HIV1-(C) infected rabbits
after 2 wk ofgrowth in IL-2-supplemented medium. As shown in Fig. 2, RT activity
was observed in cell-free culture (and A3 .01 coculture) supernatants ofPBL obtained
from HIV-1- and HTLV1/HIV1-infected rabbits. Supernatants positive for RT ac-
tivity also showed moderate to high levels of HIV-1 p24 antigen as measured by an
antigen capture assay (data not shown). No RT activity or p24 antigen was seen
in PBL cultures or cocultures from rabbits infected with HTLV1 alone or injected
with uninfected A3 .01 cells.
Confirmation that PBL were infected with HIV-1 was given by analysis of PCR-
amplified DNA from A3.01 cellscultured with supernatants from PBL from infected
rabbits. The bands (Fig. 3) indicated by ethidium bromide staining were of the
predicted size for the intact (574 bp) and Hind III-digested gag gene fragments
(448 bp) for the isolate used here (13) and most reported HIVA sequences. Further
proof that the PCR fragments are HIVI derived is given by Southern blot analysis
using a probe derived from the gag region ofthe HIV-1 proviral genome (Fig. 3, right).
Clinical Effects of HIV-I Infection.
￿
Rabbits infected with HTLV1 or HIVI alone
showed no consistent signs of illness . Of the six rabbits infected with both HTLV1
and HIV1, all had severe diarrhea and two animals suffered losses of -15 0 /c body
weight. Another in this group developed a rapidly progressing mammary adenocar-
cinoma, a rare tumor in rabbits that have never borne offspring. Two of the rabbits
displayed transient (ti5 d) paralysis of the hind legs .
A rabbit infected with HIV-1 alone was killed at 8 wk post-infection. The spleen
was enlarged and hyperplastic, and the lungs of this animal displayed lymphocyticKULAGA ET AL .
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FIGURE 1 .
￿
Photomicrographs of IL-
2-culturedPBLfrom rabbits . (A) non-
infected control ; (B) HIV-1 infected ;
(C) HTLVl/HIVl infected .
infiltration . Flow cytometry ofspleen cells using antibodies against humanand rabbit
lymphoid cell markers (14) revealed predominantly rabbit T cells; no evidence of
residual A3 .01 cells was noted (data not shown) .
Organs from two HTLU/HIV1-infected rabbits were submitted to pathology 3
FIGURE 2 . Reverse transcriptase
(RT) activity in supernatants taken
from rabbitPBLcultured with IL-
2 (gray bar) orcocultured in the pres-
ence of human A3.01 cells (black
bars) . Infection protocols and times
post-infection at which PBL were
taken are shown in the figure . The
RT assay wasperformed using 10
wl of cell-free supernatant, the open
bar shows RT activity of control-
infected A3.01 culture .324
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(Leftpaneo Agarose gel electrophoresis ofthe amplification products from PCR using
HIV-1 gag gene primers based on the sequence of the BRU isolate of HIV-1 (13) andDNA iso-
lated from A3.01 cells incubated with supernatants from cultured rabbit PBL (see Fig . 2 for rabbit
identification) . The lane marked Std contains ,oX 174 DNA digested with Hae III as size stan-
dards ; the numbers to the left indicate fragment sizes in bp ; lane 1 contains products from PCR
using input DNA from A3.01 cells infected with supernatants from rabbit 6517 PBL ; lane 2,
rabbit 50 ; lane 3, rabbit 53 . Lanes 5, 6, and 7 contain the PCR products from lanes 1, 2, and
3, respectively, after digestion with Hind III . (Right paneo Southern blot analysis of lanes 1, 2,
and 3 of the gel shown at the left using an HIV-1 gag probe (12) . Dots in the lane marked Std
indicate positions of ~oX 174 DNA fragments used as size standards .
mo after HIV-1 infection . Splenic hyperplasiaand lymphocytic lung infiltration were
diagnosed in both and moderate kidney and liver damage was seen . Coculture of
the spleens with A3 .01 cells yielded RT+ supernatants .
Discussion
The in vivo infections described here were based on results (6) showing replica-
tion of HIV I in transformed rabbit T cell and macrophage lines but not in PBL
from normal rabbits . It was reasoned from reports utilizing HTLV 1 to infect rabbits
(9, 15, 16) and from reported negative results using purified HIV-1 (17) that rabbits
could not be infected without some manipulation to render them susceptible . Ac-
cordingly, animals were first infected with HTLV1, and then injected with a human
cell line infected with HIV-1 . As shown by the present results, preinfection is not
necessary to achieve infection although antibody concentrations were higher and
disease symptoms more pronounced in the HTLV1/HIV1-infected group .
Several key questions remain concerning the infection of rabbits with HIV 1 . The
most effective means of infection and of transmission are yet to be established . The
precise mechanism of infection is obscure ; it is not known whether it is similar to
that determined for primates . Circumstances under which disease is consistentlyKULAGA ET AL.
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produced in this species need to be elucidated. A critical issue relates to determina-
tion of the effects of HIV-1 on immunologic status in the rabbit; it is not known
whether immune deficiencyresults. A complete answer to this question will require
acquisition of new basic information concerning the immune system of the rabbit.
There is also the possibility that predisposition to HIV-1-induced disease involves
genetic factors. Recently it was shown that certain inbred rabbits are prone to leukemia-
like disease when exposed to HTLV1 (15, 16) whereas normal rabbits show no signs
of HTLV1-induced disease.
The experiments described here, as well as those recently reported by others (7),
indicate that the rabbit may serve as a model for infection with HIV-1, the causative
agent in the disease AIDS. Advantages over existing models include availability of
animals, relatively lower maintenance costs, and the use of HIV-1 rather than related
viruses. Clearly, further information is required for a complete comprehension of
the HIV-1 infection process in rabbits, but the model described here offers an im-
mediate opportunity to investigate prophylactic and therapeutic agents directed against
HIV-1 infections.
Summary
Injection ofrabbits with a human T cell line infected with HIV-1 caused serocon-
version within 6 wk, and HIV-1 could be isolated from PBL cultures ofinfected rabbits.
Identity of the isolated virus with HIV-1 was shown by analysis ofproducts amplified
by the polymerase chain reaction . HIV-1 infection was seen in rabbits injected with
HIV-1-infected cells alone as well as in those that were first infected with HTLV-1
and subsequently with HIV1 . There were no consistent signs ofdisease in the rabbits
infected with HIV-1 alone but HTLV1/HIV1-infected rabbits showed signs of ill-
ness including diarrhea and weight loss, transient neurologic impairment and, in
one animal, a rapidly progressing mammary adenocarcinoma. Examination of organs
taken at necropsy from both HIV-1- and HTLV1/HIV1-infected animals showed
splenic hyperplasia and lymphocyte infiltration of the lungs, as well as moderate
damage to liver and kidney in some cases.
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